XSHE
000990
Market cap1.61bUSD
Oct 09, Last price
6.41CNY
1D
0.94%
1Q
2.56%
Jan 2017
-42.46%
IPO
-16.64%
Name
Chengzhi Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Chengzhi Shareholding Co., Ltd. engages in diverse business operations within China, encompassing clean energy, advanced functional materials, healthcare, and biotechnological fields. The company supplies specialized materials, such as liquid crystal and various chemicals essential for display technologies, alongside a range of daily and niche chemical products. Its extensive portfolio also includes edible fats and oils, a wide array of paper goods (including sanitary and household items), components for the automotive, machinery, and electronics industries, and biopharmaceutical products. Additionally, Chengzhi provides services in consulting, property management, and hospital investment management. Established in 1998, the company's main office is located in Nanchang, China.
Key people
Dawei Long
Chairman of the Board · since 2011
Jin Liang
Chief Financial Officer · since 2022
Yonghua Zou
Chief Human Resources Officer, Executive Vice President · since 2024
Lianyan Jiang
Vice President · since 2021
Baojian Qin
Vice President · since 2021
Bin Tan
Vice President · since 2024
Xin Wang
Vice President · since 2023
Hao Zuo
Vice President, Secretary of the Board · since 2024
Jing Li
Staff Elected Director · since 2025
Rui Li
Vice President, Director · since 2022
Junmin Wei
President, Director · since 2022
Zhibin Xu
Vice Chairman of the Board · since 2022
Jianye Wang
Independent Director · since 2022
Xinxin Wang
Independent Director · since 2022
Independent Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||